Expansion of α-galactosylceramide-stimulated Vα24+ NKT cells cultured in the absence of animal materials

Yukie Harada, Osamu Imataki, Yuji Heike, Hiroyuki Kawai, Akihiro Shimosaka, Shin Ichiro Mori, Masahiro Kami, Ryuji Tanosaki, Yoshinori Ikarashi, Akira Iizuka, Mitsuji Yoshida, Hiro Wakasugi, Shigeru Saito, Yoichi Takaue, Masao Takei, Tadao Kakizoe

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Vα24+ NKT is an innate lymphocyte with potential antitumor activity. Clinical applications of Vα24+ natural killer (NK) T cells, which are innate lymphocytes with potential antitumor activity, require their in vitro expansion. To avoid the potential dangers posed to patients by fetal bovine serum (FBS), the authors evaluated non-FBS culture conditions for the selective and efficient expansion of human Vα24+ NKT cells. Mononuclear cells (MNCs) and plasma from the peripheral blood of normal healthy donors were used before and after G-CSF mobilization. MNCs and plasma separated from apheresis products were also used. MNCs were cultured for 12 days in AIM-V medium containing α-galactosylceramide (α-GalCer) (100 ng/mL) and IL-2 (100 U/mL) supplemented with FBS, autologous plasma, or autologous serum. The cultured cells were collected and their surface markers, intracellular cytokines, and cytotoxicity were evaluated. The highest expansion ratio for Vα24+ NKT cells was obtained from G-CSF-mobilized MNCs cultured in medium containing 5% autologous plasma. Cultures containing MNCs and autologous plasma obtained before and after G-CSF mobilization had approximately 350-fold and 2,000-fold expansion ratios, respectively. These results suggest that G-CSF mobilization conferred a proliferative advantage to Vα24 + NKT cells by modifying the biology of cells and plasma factors. Expanded Vα24+ NKT cells retained their surface antigen expression and production of IFN-γ and exhibited CD1d-independent cytotoxicity against tumor cells. Vα24+ NKT cells can be efficiently expanded from G-CSF-mobilized peripheral blood MNCs in non-FBS culture conditions with α-GalCer and IL-2.

Original languageEnglish
Pages (from-to)314-321
Number of pages8
JournalJournal of Immunotherapy
Volume28
Issue number4
Publication statusPublished - 2005 Jul
Externally publishedYes

Fingerprint

Galactosylceramides
Natural Killer T-Cells
Granulocyte Colony-Stimulating Factor
Plasma Cells
Cultured Cells
Serum
Interleukin-2
Lymphocytes
Blood Component Removal
Surface Antigens
Cell Biology
Blood Cells
Tissue Donors
Cytokines
Neoplasms

Keywords

  • α-galactosylceramide
  • G-CSF
  • NKT cells

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Immunology

Cite this

Harada, Y., Imataki, O., Heike, Y., Kawai, H., Shimosaka, A., Mori, S. I., ... Kakizoe, T. (2005). Expansion of α-galactosylceramide-stimulated Vα24+ NKT cells cultured in the absence of animal materials. Journal of Immunotherapy, 28(4), 314-321.

Expansion of α-galactosylceramide-stimulated Vα24+ NKT cells cultured in the absence of animal materials. / Harada, Yukie; Imataki, Osamu; Heike, Yuji; Kawai, Hiroyuki; Shimosaka, Akihiro; Mori, Shin Ichiro; Kami, Masahiro; Tanosaki, Ryuji; Ikarashi, Yoshinori; Iizuka, Akira; Yoshida, Mitsuji; Wakasugi, Hiro; Saito, Shigeru; Takaue, Yoichi; Takei, Masao; Kakizoe, Tadao.

In: Journal of Immunotherapy, Vol. 28, No. 4, 07.2005, p. 314-321.

Research output: Contribution to journalArticle

Harada, Y, Imataki, O, Heike, Y, Kawai, H, Shimosaka, A, Mori, SI, Kami, M, Tanosaki, R, Ikarashi, Y, Iizuka, A, Yoshida, M, Wakasugi, H, Saito, S, Takaue, Y, Takei, M & Kakizoe, T 2005, 'Expansion of α-galactosylceramide-stimulated Vα24+ NKT cells cultured in the absence of animal materials', Journal of Immunotherapy, vol. 28, no. 4, pp. 314-321.
Harada Y, Imataki O, Heike Y, Kawai H, Shimosaka A, Mori SI et al. Expansion of α-galactosylceramide-stimulated Vα24+ NKT cells cultured in the absence of animal materials. Journal of Immunotherapy. 2005 Jul;28(4):314-321.
Harada, Yukie ; Imataki, Osamu ; Heike, Yuji ; Kawai, Hiroyuki ; Shimosaka, Akihiro ; Mori, Shin Ichiro ; Kami, Masahiro ; Tanosaki, Ryuji ; Ikarashi, Yoshinori ; Iizuka, Akira ; Yoshida, Mitsuji ; Wakasugi, Hiro ; Saito, Shigeru ; Takaue, Yoichi ; Takei, Masao ; Kakizoe, Tadao. / Expansion of α-galactosylceramide-stimulated Vα24+ NKT cells cultured in the absence of animal materials. In: Journal of Immunotherapy. 2005 ; Vol. 28, No. 4. pp. 314-321.
@article{69ba475086de49e9af38315a7dd69704,
title = "Expansion of α-galactosylceramide-stimulated Vα24+ NKT cells cultured in the absence of animal materials",
abstract = "Vα24+ NKT is an innate lymphocyte with potential antitumor activity. Clinical applications of Vα24+ natural killer (NK) T cells, which are innate lymphocytes with potential antitumor activity, require their in vitro expansion. To avoid the potential dangers posed to patients by fetal bovine serum (FBS), the authors evaluated non-FBS culture conditions for the selective and efficient expansion of human Vα24+ NKT cells. Mononuclear cells (MNCs) and plasma from the peripheral blood of normal healthy donors were used before and after G-CSF mobilization. MNCs and plasma separated from apheresis products were also used. MNCs were cultured for 12 days in AIM-V medium containing α-galactosylceramide (α-GalCer) (100 ng/mL) and IL-2 (100 U/mL) supplemented with FBS, autologous plasma, or autologous serum. The cultured cells were collected and their surface markers, intracellular cytokines, and cytotoxicity were evaluated. The highest expansion ratio for Vα24+ NKT cells was obtained from G-CSF-mobilized MNCs cultured in medium containing 5{\%} autologous plasma. Cultures containing MNCs and autologous plasma obtained before and after G-CSF mobilization had approximately 350-fold and 2,000-fold expansion ratios, respectively. These results suggest that G-CSF mobilization conferred a proliferative advantage to Vα24 + NKT cells by modifying the biology of cells and plasma factors. Expanded Vα24+ NKT cells retained their surface antigen expression and production of IFN-γ and exhibited CD1d-independent cytotoxicity against tumor cells. Vα24+ NKT cells can be efficiently expanded from G-CSF-mobilized peripheral blood MNCs in non-FBS culture conditions with α-GalCer and IL-2.",
keywords = "α-galactosylceramide, G-CSF, NKT cells",
author = "Yukie Harada and Osamu Imataki and Yuji Heike and Hiroyuki Kawai and Akihiro Shimosaka and Mori, {Shin Ichiro} and Masahiro Kami and Ryuji Tanosaki and Yoshinori Ikarashi and Akira Iizuka and Mitsuji Yoshida and Hiro Wakasugi and Shigeru Saito and Yoichi Takaue and Masao Takei and Tadao Kakizoe",
year = "2005",
month = "7",
language = "English",
volume = "28",
pages = "314--321",
journal = "Journal of Immunotherapy",
issn = "1053-8550",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Expansion of α-galactosylceramide-stimulated Vα24+ NKT cells cultured in the absence of animal materials

AU - Harada, Yukie

AU - Imataki, Osamu

AU - Heike, Yuji

AU - Kawai, Hiroyuki

AU - Shimosaka, Akihiro

AU - Mori, Shin Ichiro

AU - Kami, Masahiro

AU - Tanosaki, Ryuji

AU - Ikarashi, Yoshinori

AU - Iizuka, Akira

AU - Yoshida, Mitsuji

AU - Wakasugi, Hiro

AU - Saito, Shigeru

AU - Takaue, Yoichi

AU - Takei, Masao

AU - Kakizoe, Tadao

PY - 2005/7

Y1 - 2005/7

N2 - Vα24+ NKT is an innate lymphocyte with potential antitumor activity. Clinical applications of Vα24+ natural killer (NK) T cells, which are innate lymphocytes with potential antitumor activity, require their in vitro expansion. To avoid the potential dangers posed to patients by fetal bovine serum (FBS), the authors evaluated non-FBS culture conditions for the selective and efficient expansion of human Vα24+ NKT cells. Mononuclear cells (MNCs) and plasma from the peripheral blood of normal healthy donors were used before and after G-CSF mobilization. MNCs and plasma separated from apheresis products were also used. MNCs were cultured for 12 days in AIM-V medium containing α-galactosylceramide (α-GalCer) (100 ng/mL) and IL-2 (100 U/mL) supplemented with FBS, autologous plasma, or autologous serum. The cultured cells were collected and their surface markers, intracellular cytokines, and cytotoxicity were evaluated. The highest expansion ratio for Vα24+ NKT cells was obtained from G-CSF-mobilized MNCs cultured in medium containing 5% autologous plasma. Cultures containing MNCs and autologous plasma obtained before and after G-CSF mobilization had approximately 350-fold and 2,000-fold expansion ratios, respectively. These results suggest that G-CSF mobilization conferred a proliferative advantage to Vα24 + NKT cells by modifying the biology of cells and plasma factors. Expanded Vα24+ NKT cells retained their surface antigen expression and production of IFN-γ and exhibited CD1d-independent cytotoxicity against tumor cells. Vα24+ NKT cells can be efficiently expanded from G-CSF-mobilized peripheral blood MNCs in non-FBS culture conditions with α-GalCer and IL-2.

AB - Vα24+ NKT is an innate lymphocyte with potential antitumor activity. Clinical applications of Vα24+ natural killer (NK) T cells, which are innate lymphocytes with potential antitumor activity, require their in vitro expansion. To avoid the potential dangers posed to patients by fetal bovine serum (FBS), the authors evaluated non-FBS culture conditions for the selective and efficient expansion of human Vα24+ NKT cells. Mononuclear cells (MNCs) and plasma from the peripheral blood of normal healthy donors were used before and after G-CSF mobilization. MNCs and plasma separated from apheresis products were also used. MNCs were cultured for 12 days in AIM-V medium containing α-galactosylceramide (α-GalCer) (100 ng/mL) and IL-2 (100 U/mL) supplemented with FBS, autologous plasma, or autologous serum. The cultured cells were collected and their surface markers, intracellular cytokines, and cytotoxicity were evaluated. The highest expansion ratio for Vα24+ NKT cells was obtained from G-CSF-mobilized MNCs cultured in medium containing 5% autologous plasma. Cultures containing MNCs and autologous plasma obtained before and after G-CSF mobilization had approximately 350-fold and 2,000-fold expansion ratios, respectively. These results suggest that G-CSF mobilization conferred a proliferative advantage to Vα24 + NKT cells by modifying the biology of cells and plasma factors. Expanded Vα24+ NKT cells retained their surface antigen expression and production of IFN-γ and exhibited CD1d-independent cytotoxicity against tumor cells. Vα24+ NKT cells can be efficiently expanded from G-CSF-mobilized peripheral blood MNCs in non-FBS culture conditions with α-GalCer and IL-2.

KW - α-galactosylceramide

KW - G-CSF

KW - NKT cells

UR - http://www.scopus.com/inward/record.url?scp=21844449937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21844449937&partnerID=8YFLogxK

M3 - Article

C2 - 16000949

AN - SCOPUS:21844449937

VL - 28

SP - 314

EP - 321

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1053-8550

IS - 4

ER -